Jiangsu Changyou Environmental Protection Technology
301557
Hefei conver Holding
603409
LIERDA
832149
4
SHENGNAN TECHNOLOGY
837006
5
CHK
831167
US Stock MarketDetailed Quotes
IMAB I-Mab
- 0.901
- -0.023-2.50%
Close Mar 4 16:00 ET
- 0.927
- +0.026+2.85%
Post 18:40 ET
73.43MMarket Cap-0.94P/E (TTM)
0.938High0.900Low598.78KVolume0.900Open0.924Pre Close549.15KTurnover1.25%Turnover RatioLossP/E (Static)81.50MShares2.00052wk High0.34P/B43.25MFloat Cap0.84152wk Low--Dividend TTM48.01MShs Float85.400Historical High--Div YieldTTM4.06%Amplitude0.841Historical Low0.917Avg Price1Lot Size
About I-Mab Company
I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
Company Profile
SymbolIMAB
Company NameI-Mab
Listing DateJan 17, 2020
Issue Price14.00
Founded2016
CEODr. Xi-Yong Sean Fu
MarketNASDAQ
Employees220
Securities TypeDR
ADS Ratio10.0 : 23.0
Fiscal Year Ends12-31
Address2440 Research Boulevard,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-745-6330
Company Executives
- Name
- Position
- Salary
- Dr. Xi-Yong Sean Fu
- Chief Executive Officer and Director
- --
- Joseph Skelton
- Chief Financial Officer
- --
- Dr. Phillip Dennis, M.D.
- Chief Medical Officer
- --
- Wei Fu
- Chairman of the Board
- --
- Chia-hung Conor Yang
- Independent Director
- --
- Lielie Zhang
- Independent Director
- --
- Chun Kwok Alan Au
- Independent Director
- --
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!